Loss of heterozygosity for 10q22-10qter in malignant melanoma progression.

Rudolf Herbst(Helios Klinikum Erfurt), Karen C. Arden(Ludwig Cancer Research), Alexander Ehnis, Webster K. Cavenee(University of California San Diego)
PubMed
June 15, 1994
Cited by 103

Related Papers

Malignant astrocytic glioma: genetics, biology, and paths to treatment
|Genes & Development|2007|2.3k
The WHO Classification of Tumors of the Nervous System
|Journal of Neuropathology & Experimental Neurology|2002|2k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
|The Lancet Oncology|2016|704